Joseph Young
Vermögen: 3 Mio $ am 30.09.2026
Vermögen: 3 Mio $ am 30.09.2026
Joseph Young is currently Chief Accounting Officer & Senior VP-Finance at Vera Therapeutics, Inc. since 2021.
Formerly, Mr. Young worked as an Auditor at Ernst & Young LLP and as Senior Vice President-Finance at Plexxikon, Inc. Mr. Young completed undergraduate studies at the University of California, Los Angeles and earned an MBA from Haas School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.09.2026 | 80.754 ( 0,11 % ) | 3 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 26.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | - |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen